| Course | PSY FPX 5201 Integrative Project for Master's Degree in Psychology |
|---|---|
| Assessment | Assessment 2 |
| Paper type | Integrative literature review |
| Length | About 1,110 words, 5 pages |
| Format | APA 7 student paper |
| School | Capella University |
| Program | MS in Psychology |
| Updated | September 2026 |
Free sample paper for PSY FPX 5201 Assessment 2
Smartphone Apps for Depressive Symptoms: An Integrative Literature Review With Headings That Name Findings, Study Quality Doing Visible Work, Counterevidence at Full Strength, and Implications Stopped at the Degree's Edge
Student Name
Capella University
PSY FPX 5201: Integrative Project for Master's Degree in Psychology
Instructor Name
Month Day, Year
The Question
The governing question is the prospectus question unchanged: for adults with depressive symptoms, what is the size of the benefit from app programs when the comparison is a waitlist, what is it when the comparison is some other activity, and how many people keep using the apps? It draws on meta-analyses of randomized controlled trials published since 2017 and on the trials they include.
Apps Reduce Symptoms More Than Doing Nothing
Against inactive controls, such as waitlists, the evidence consistently favors apps. Firth et al. (2017), combining 18 randomized trials with 3,414 participants, found a moderate effect against inactive controls, g = 0.56. Linardon et al. (2019), combining a larger set of trials, found an overall effect on depressive symptoms of g = 0.28 across all control types, with most effects robust after adjusting for the type of control and for risk of bias. This finding is well supported: it rests on randomized trials, it appears in more than one independent meta-analysis, and Firth et al. found no evidence of publication bias in their set. The two meta-analyses differ in size because they included different sets of trials and different control types; Linardon et al.'s smaller overall figure combines inactive and active comparisons, which is consistent with Firth et al.'s finding that the effect depends on the comparison. Study quality does visible work even here. Most trials measured symptoms by self-report, and participants in an app condition know they are receiving an intervention while waitlist participants know they are not. Some of the advantage over inactive controls may reflect expectation rather than the app's content, which is exactly why the comparison with active controls matters.
Against Active Controls, the Advantage Is Small
When apps are compared with an active control, such as an app with no therapeutic content or another form of support, the advantage shrinks. Firth et al. (2017) found g = 0.22 against active controls, a small effect. Linardon et al. (2019) found that apps did not differ significantly from active interventions such as face-to-face or computerized treatment, though they noted that few trials made that comparison. This is the most important finding for practice. It suggests that a meaningful part of the benefit seen in waitlist-controlled trials comes from engaging with something, attention, expectation, or structure, rather than from the specific therapeutic content of the app. It does not mean the content is useless; a small specific effect on top of a general effect may still be worth having. But it changes what a case manager can honestly say: the evidence supports doing something structured over doing nothing more clearly than it supports any particular app's content. Much of what makes an app look effective against a waitlist also appears when people use an app with no treatment in it.
Guided, CBT-Based Apps Show Larger Effects
Not all apps perform alike. Linardon et al. (2019) found that apps based on cognitive behavioral therapy, and those that offered professional guidance and engagement reminders, produced larger effects across several outcomes. Firth et al. (2017) found that cognitive training apps had smaller effects on depression than apps focused on mental health. These comparisons are between trials rather than within them, so they are suggestive: guided CBT apps may differ from others in ways besides their content, such as the populations they were tested in. A trial that randomly assigned people to the same app with and without guidance would settle the question, and the review found few such trials.
Many Users Stop Early, and Published Rates Understate It
The strongest counterevidence concerns engagement, and it deserves full weight. Torous et al. (2020) pooled 18 randomized trials and estimated that just over a quarter of participants (26.2%) left before the end; once missing studies were accounted for, the estimate climbed to almost half (47.8%). Dropout was lower in trials that offered human feedback and in-app mood monitoring. These rates come from research trials, where participants are recruited, screened, often paid for assessments, and contacted by study staff; outside trials, where no one follows up, engagement is likely lower still. This matters for interpreting every effect estimate above. If nearly half of participants might leave a trial, the people who remain and are measured may be those most likely to benefit, and the estimated effects may describe committed users rather than everyone offered an app. The engagement evidence does not show that apps fail, but it limits how far their average effects can be applied to a typical client. It also suggests a practical lever: if human contact reduces dropout, then a case manager's follow-up call may be part of what makes an app worthwhile.
Study Quality Across the Literature
Across the meta-analyses, the trials share common weaknesses: reliance on self-reported symptoms, short follow-up, often eight weeks or less, samples that are often recruited online and may differ from clinical populations, and uneven reporting of engagement. Their strengths are randomization and, in the meta-analyses, attention to publication bias and control type. The overall body of evidence supports modest conclusions with confidence and larger conclusions only tentatively. In practical terms, the review is confident that apps help relative to waiting, moderately confident that the specific benefit beyond engagement is small, and uncertain about how long any benefit lasts.
Implications Stopped at the Degree's Edge
The review's implications are stated for a master's-level case manager, not for a licensed clinician. A case manager can tell clients on a waiting list that evidence supports some depression apps as a modest help compared with doing nothing, especially apps based on cognitive behavioral therapy; that many people stop using them, so checking in helps; and that an app is not a substitute for assessment and treatment. The review does not support a case manager recommending an app in place of therapy, judging whether a client's symptoms are mild enough for self-help alone, or monitoring risk through app data. Those decisions belong to licensed clinicians and to the agency's protocols.
Conclusion
Smartphone apps reduce depressive symptoms more than inactive controls, but their advantage over active controls is small, guided CBT-based apps appear to do better, and dropout is high enough to limit how far average effects apply. For a case manager, the evidence supports apps as a modest supplement during a wait, offered with follow-up, and not as a replacement for care.
References
Firth, J., Torous, J., Nicholas, J., Carney, R., Pratap, A., Rosenbaum, S., & Sarris, J. (2017). The efficacy of smartphone-based mental health interventions for depressive symptoms: A meta-analysis of randomized controlled trials. World Psychiatry, 16(3), 287-298. https://doi.org/10.1002/wps.20472
Linardon, J., Cuijpers, P., Carlbring, P., Messer, M., & Fuller-Tyszkiewicz, M. (2019). The efficacy of app-supported smartphone interventions for mental health problems: A meta-analysis of randomized controlled trials. World Psychiatry, 18(3), 325-336. https://doi.org/10.1002/wps.20673
Torous, J., Lipschitz, J., Ng, M., & Firth, J. (2020). Dropout rates in clinical trials of smartphone apps for depressive symptoms: A systematic review and meta-analysis. Journal of Affective Disorders, 263, 413-419. https://doi.org/10.1016/j.jad.2019.11.167
PSY FPX 5201 Assessment 2 instructions, in plain terms
Assessment 2 in PSY FPX 5201 has you complete the integrative review proposed in the prospectus. You search and select studies using your stated criteria, appraise their quality, organize the review around findings, weigh evidence according to study quality, present evidence against your emerging conclusions fairly, synthesize what the research shows and discuss implications within the scope of practice for a master's-level professional. The review should integrate rather than summarize. Recent meta-analyses of digital mental health interventions and individual randomized trials support the review.
How the PSY-FPX5201 Assessment 2 example is put together
The review is spined rather than sectioned. An introduction restates the question and states the thesis the document will defend, so a reader knows from the first page what is being argued. A method section describes how the literature was located and appraised, which databases, which terms, which inclusion rules, and what separated a study kept from a study set aside. The body then runs in claim sections, each establishing one piece of the argument from grouped studies and closing with what that piece supports. A dedicated section takes up the case against the thesis, presenting the opposing evidence in its own best form before responding to it. A synthesis section assembles the pieces into the answer, stated at the strength the record allows. Implications and limitations close, with the limitations analytic rather than ritual and the implications bounded by what a non-clinical review can license.
PSY FPX 5201 Assessment 2 scoring guide: what Distinguished looks like
Marks go to the finding-based headings, the visible role of study quality, the treatment of counterevidence, the synthesis and the scope of implications. Headings reach Distinguished when each names a finding, such as "Effects shrink against active controls," rather than a topic. Study quality scores higher when it visibly changes how much weight a finding gets, with high risk-of-bias trials discounted. Counterevidence earns credit when presented at full strength rather than dismissed. The synthesis is judged on whether it reaches a conclusion across studies. Implications should stop at the degree's edge, avoiding clinical treatment recommendations beyond master's scope. Selection criteria from the prospectus should be followed. Distinguished reviews are integrative and appropriately cautious.
PSY FPX 5201 Assessment 2 help: mistakes that cost marks
Integrative reviews often use topic headings, like "Study 1" or "Apps," which lead to summaries rather than synthesis. A second problem is giving every study the same weight, so small unblinded trials carry the same weight as large rigorous ones. Counterevidence is mentioned briefly and dismissed. The synthesis restates individual findings without drawing them together. Implications overreach, recommending specific treatments a master's graduate is not licensed to provide. The selection criteria from the prospectus are quietly abandoned. Writing each heading as a finding, then placing the strongest studies first under it, keeps the review integrative and prepares the final presentation in Assessment 3.
Get a PSY FPX 5201 Assessment 2 example written to your instructions
Hand across the Assessment 2 guidelines and scoring guide from your PSY FPX 5201 section, plus your approved question and the sources you have gathered so far. The review is drafted to those criteria and arrives inside 24-48h, with no fee on a first custom sample. It demonstrates proportion and adjudication; the argument you defend must come from your own reading. The paper above is an original model document written by our desk, not a submitted student paper and not an official Capella University document.
More PSY FPX 5201 papers and MS in Psychology samples
- PSY FPX 5201 Assessment 1: Project Prospectus
- PSY FPX 5201 Assessment 3: Final Project Presentation
- PSY FPX 6010 Assessment 2: Teratogen Research Review
- PSY FPX 5140 Assessment 2: Program Evaluation Design
- PSY FPX 6015 Assessment 2: Case Conceptualization
- PSY FPX 5120 Assessment 2: Group Process Analysis
PSY FPX 5201 Assessment 2 questions, answered
How do I organize a review by findings rather than by study?
Write down the three or four things your reading has convinced you of, then make each one a section and gather under it the studies that bear on it, supporting or not. Any source that fits nowhere is either irrelevant or is telling you a claim is missing. The structure that results looks like an argument because it was built from one.
How much counterevidence is enough?
Enough that a reader who disagrees with you would recognize their best argument in your pages. That usually means the two or three strongest studies against your thesis, presented without softening, and answered on methodological or conceptual grounds rather than dismissed. A review that meets only weak opposition has demonstrated nothing about the strength of its own position.
Can the review recommend clinical practice?
Only as far as the degree and the evidence allow, which is usually not far. A non-clinical master's review can say what the literature suggests for practitioners, for program design or for further research; it cannot prescribe treatment, and criteria in this course watch that line closely. State the implication, then state its boundary, and let the reader with clinical authority carry it further.
Where can I find a free PSY FPX 5201 Assessment 2 sample paper?
This page presents the depression app integrative review, with headings that name findings, study quality doing visible work, counterevidence at full strength and implications stopped at the degree's edge.
How do I organize a review by findings in PSY FPX 5201 Assessment 2?
Group studies under statements of what they show, such as "apps outperform waitlists," and discuss the studies supporting and challenging each statement together.